Hi Plow. I don't think the main complaints are with the ctuall running of the business, but rather the neglect of the public side of the company. Lack of consistent communication with current shareholders, lack of engagement with potential investors, etc.
I agree OTCs are high risk, but disagree that the huge loss us longs have taken (down near 95%) are completely on us. We need a management team that also looks out for us and helps protect our investment. Right now we don't have that...